AUNA S.A.

Auna S.A. announced a preliminary update to its full-year 2026 outlook. While revenue growth is expected to be in line with prior guidance, supported by a strong recovery in Mexico, the company now anticipates its Adjusted EBITDA performance to be broadly stable year over year, a reduction from previous expectations. This adjustment is primarily due to temporary cost pressures from a specific payor contract in Colombia related to a high incidence of advanced cancer cases. Capital expenditures, Free Cash Flow, and leverage are expected to remain within guidance. Auna will host an Investor Day today to discuss its long-term strategy.

Auna S.A. reported preliminary key performance indicators for the second quarter ended June 30, 2026, showing growth across its operations in Mexico, Peru, and Colombia. The company saw increases in surgeries and chemotherapy/radiotherapy sessions in Mexico, and significant growth in emergency treatments and capacity utilization in Peru. Additionally, plan memberships in OncoSalud Peru and protected lives in Colombia demonstrated strong upward trends.

Auna S.A. announced the results of its Annual General Meeting held on June 30, 2026, where shareholders approved the 2025 financial reports, granted discharge to directors and the statutory auditor, and ratified director remuneration. Separately, the company updated its board composition, with Jorge Basadre and Guadalupe Phillips stepping down, effective July 6, 2026. The Board will now consist of seven members and will continue to have a majority of independent directors.

AUNA S.A. has announced its Annual General Meeting of shareholders to be held on June 30, 2026, in Luxembourg. The agenda includes the confirmation of share awards to independent directors, the presentation and approval of the 2025 separate and consolidated financial statements, and the related management and auditor reports. Shareholders will also vote on the discharge of directors and the statutory auditor for the 2025 financial year, as well as the reappointment of the auditor for 2026. Additionally, the ratification of director remunerations and compensations will be on the agenda.

Auna reported mixed financial results for Q1 2026, with strong top-line growth and significant improvements in cash flow, but a decline in consolidated Adjusted EBITDA and Net Income. Revenue increased 13% year-over-year to S/1,178 million, and operating cash flow surged 48%. However, consolidated Adjusted EBITDA decreased 2% YoY to S/217 million, primarily due to revenue adjustments in Peru and talent investments in Mexico, while Net Income was heavily impacted by non-cash FX losses. The company reaffirmed its full-year revenue and Adjusted EBITDA guidance, citing improving trends across all markets.